SCHEMBL17852147

SCHEMBL17852147

Brc1cccc2c1Cc1cc3ccccc3cc1-2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 4/20 0.39
TSHR P16473 3/20 0.39
HSD17B10 Q99714 3/20 0.39
ALDH1A1 P00352 3/20 0.39
TP53 P04637 2/20 0.39
HPGD P15428 2/20 0.39
CASP1 P29466 2/20 0.39
HIF1A Q16665 2/20 0.39
CASP7 P55210 1/20 0.39
TRPA1 O75762 1/20 0.37
PIM1 P11309 1/20 0.36
CSNK1A1 P48729 1/20 0.36
CDK5 Q00535 1/20 0.36
ROCK1 Q13464 1/20 0.36
DYRK1A Q13627 1/20 0.36
LRRK2 Q5S007 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
DYRK1B Q9Y463 1/20 0.36
HSP90AA1 P07900 2/20 0.36
MAOA P21397 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26014066 0.80 TDP1 (0.42) MAPK1TRPA1PIM1CSNK1A1CDK5
SCHEMBL2573139 0.79 PNMT (0.53) MAPK1ALDH1A1HPGDTRPA1PIM1
SCHEMBL29420140 0.79 PGR (0.48) MAPK1TSHRHSD17B10ALDH1A1TP53
SCHEMBL30714854 0.79 CA1 (0.41) MAPK1TSHRHSD17B10ALDH1A1TP53
SCHEMBL30954660 0.79 PRCP (0.40) MAPK1TSHRHSD17B10ALDH1A1TP53
SCHEMBL20484771 0.77 MEN1 (0.40) MAPK1TSHRHSD17B10TP53TRPA1
SCHEMBL30569651 0.76 CA1 (0.47) ALDH1A1HPGDTRPA1PIM1CSNK1A1
SCHEMBL30771568 0.76 CA1 (0.47) ALDH1A1HPGDTRPA1PIM1CSNK1A1
SCHEMBL17283495 0.76 ALDH1A1 (0.52) MAPK1TSHRHSD17B10ALDH1A1TP53
SCHEMBL30771567 0.76 CA1 (0.47) ALDH1A1HPGDTRPA1PIM1CSNK1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160181542-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed
US-20160181542-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160181542-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME L1CAM, H1-10, H1-0 MAPK1 905/4885TSHR 1572/4885HSD17B10 901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.